Academic Publications. The Principal Investigator and other members of the TAU Team shall have the right to publish the Ramot Technology and the Joint Technology in scientific publications or to present such results at scientific symposia, provided that the following procedure is followed: 9.2.1. No later than thirty (30) days prior to submission for publication of any scientific articles, abstracts or papers concerning the Ramot Technology or the Joint Technology and prior to the presentation of the same at any scientific symposia, the Principal Investigator shall send the Company a written copy of the material to be so submitted or presented, and shall allow the Company to review such submission to determine whether the publication or presentation contains subject matter for which patent protection should be sought and whether such publication includes Company Confidential Information. 9.2.2. The Company shall provide its written comments with respect to such publication or presentation within thirty (30) days following its receipt of such written material. If the Company does not provide written comments within the thirty (30) days set forth above, it shall be deemed to have approved such proposed publication or presentation. 9.2.3. If the Company, in its written comments, identifies material for which patent protection should be sought, then the Principal Investigator shall delay the submission of such publication or presentation for a further period of up to sixty (60) days from the receipt of such written comments to enable Ramot to make the necessary patent filings in accordance with Section 4.
Appears in 3 contracts
Samples: License and Research Funding Agreement, License and Research Funding Agreement (Online Disruptive Technologies, Inc.), License and Research Funding Agreement (Online Disruptive Technologies, Inc.)
Academic Publications. The Principal Investigator and other members of the TAU Team shall have the right to publish the Ramot Technology and the Joint Technology in scientific publications or to present such results at scientific symposia, provided that the following procedure is followed:
9.2.1. No later than thirty (30) days prior to submission for publication of any scientific articles, abstracts or papers concerning the Ramot Technology or the Joint Technology and prior to the presentation of the same at any scientific symposia, the Principal Investigator shall send the Company a written copy of the material to be so submitted or presented, and shall allow the Company to review such submission to determine whether the publication or presentation contains subject matter for which patent protection should be sought and whether such publication includes Company Confidential Informationsought.
9.2.2. The Company shall provide its written comments with respect to such publication or presentation within thirty (30) days following its receipt of such written material. If the Company does not provide written comments within the thirty (30) days set forth above, it shall be deemed to have approved such proposed publication or presentation.
9.2.3. If the Company, in its written comments, identifies material for which patent protection should be sought, then the Principal Investigator shall delay the submission of such publication or presentation for a further period of up to sixty (60) days from the receipt of such written comments to enable Ramot to make the necessary patent filings in accordance with Section 4.
9.2.4. If the Company, in its written comments, identifies Company Confidential Information in the material to be published, such Company Confidential Information shall be removed prior to publication.
Appears in 2 contracts
Samples: Research Funding and License Agreement (Therapix Biosciences Ltd.), Research Funding and License Agreement (Therapix Biosciences Ltd.)
Academic Publications. The Principal Investigator and other members of the TAU Team shall have the right to publish the Ramot Technology and the Joint Technology with respect to the Field in scientific publications or to present such results at scientific symposia, provided that the following procedure is followed:
9.2.1. No later than thirty (30) days prior to submission for publication of any scientific articles, abstracts or papers concerning the Ramot Technology or the Joint Technology with respect to the Field and prior to the presentation of the same at any scientific symposia, the Principal Investigator shall send the Company a written copy of the material to be so submitted or presented, and shall allow the Company to review such submission to determine whether the publication or presentation contains subject matter for which patent protection should be sought and whether such publication includes Company Confidential Informationsought.
9.2.2. The Company shall provide its written comments with respect to such publication or presentation within thirty (30) days following its receipt of such written material. If the Company does not provide written comments within the thirty (30) days set forth above, it shall be deemed to have approved such proposed publication or presentation.it
9.2.3. If the Company, in its written comments, identifies material for which patent protection should be sought, then the Principal Investigator shall delay the submission publication of such publication or presentation for a further period of up to presentation, so that it is no earlier than sixty (60) days from the receipt of such written comments comments, in order to enable Ramot to make the necessary patent filings in accordance with Section 4. For avoidance of doubt, if Ramot has filed a patent application prior to the end of the 60-day period, the publication may be made as soon as such application has been filed.
9.2.4. If the Company, in its written comments, identifies Company Confidential Information in the material to be published, such Company Confidential Information shall be removed prior to publication.
Appears in 1 contract
Academic Publications. The Principal Investigator and R&D Manager and other members of the TAU AU Team shall have the right to publish the Ramot Technology and the Joint Ariel Technology in scientific publications or to present such results at scientific symposia, provided that the following procedure is followed:
9.2.1. No later than thirty (30) business days prior to submission for publication of any scientific articles, abstracts or papers concerning the Ramot Technology or the Joint Ariel Technology and prior to the presentation of the same at any scientific symposia, the Principal Investigator shall send the Company a written copy of the material to be so submitted or presented, and shall allow the Company to review such submission to determine whether the publication or presentation contains subject matter for which patent protection should be sought and whether such publication includes Company Confidential Information.. ]
9.2.2. The Company shall provide its written comments with respect to such publication or presentation within thirty (30) business days following its receipt of such written material. If the Company does not provide written comments within the thirty (30) days set forth above, it shall be deemed to have approved such proposed publication or presentation.
9.2.3. If the Company, in its written comments, identifies material for which patent protection should be soughtsought or wishes to delay the publication for specific business reasons , then the Principal Investigator shall delay the submission of such publication or presentation for a further period of up to sixty ninety (6090) business days from the receipt of such written comments to enable Ramot Ariel to make the necessary patent filings in accordance with Section 4.
Appears in 1 contract
Samples: License and Research Funding Agreement (Biolabmart Inc.)